We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEPH icon
13101
Nephros
NEPH
$50.3M
$16.7K ﹤0.01%
15,295
-3,045
-17% -$3.5K
LILA icon
13102
PUT
Liberty Latin America Class A
LILA
$1.69B
$16.6K ﹤0.01%
2,944
+589
+25% +$3.5K
RAIN
13103
PUT
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$16.6K ﹤0.01%
1,900
+1,800
+1,800% +$16.6K
SPRU icon
13104
PUT
Spruce Power Holding Corp
SPRU
$35.4M
$16.6K ﹤0.01%
2,525
-4,138
-62% -$35.4K
NMTR
13105
PUT
DELISTED
9 Meters Biopharma
NMTR
$16.5K ﹤0.01%
11,900
+8,735
+276% +$16.5K
BTOG icon
13106
Bit Origin
BTOG
$3.41M
$16.5K ﹤0.01%
33
+13
+65% +$6.06K
ATRA icon
13107
PUT
Atara Biotherapeutics
ATRA
$81.2M
$16.5K ﹤0.01%
228
-44
-16% -$4.27K
CYXT
13108
PUT
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$16.5K ﹤0.01%
54,100
+33,600
+164% +$71K
ASTE icon
13109
CALL
Astec Industries
ASTE
$997M
$16.5K ﹤0.01%
400
-800
-67% -$33.8K
AKLI
13110
CALL
DELISTED
Akili Inc
AKLI
$16.5K ﹤0.01%
10,300
-8,800
-46% -$13.7K
JOBY icon
13111
Joby Aviation
JOBY
$7.83B
$16.5K ﹤0.01%
3,796
CBD
13112
CALL
DELISTED
Companhia Brasileira de Distribuicao
CBD
$16.5K ﹤0.01%
5,600
+300
+6% +$973
HYFM icon
13113
PUT
Hydrofarm Holdings
HYFM
$7M
$16.4K ﹤0.01%
950
-2,400
-72% -$42.5K
LYRA
13114
DELISTED
LYRA THERAPEUTICS INC
LYRA
$16.4K ﹤0.01%
159
-347
-69% -$43K
ORGO icon
13115
CALL
Organogenesis Holdings
ORGO
$230M
$16.4K ﹤0.01%
7,700
-2,000
-21% -$4.94K
SWKS icon
13116
Skyworks Solutions
SWKS
$10.5B
$16.4K ﹤0.01%
139
-553,154
-100% -$61.3M
UFOX
13117
PUT
Defiance Space and Connective Tech ETF
UFOX
$923M
$16.4K ﹤0.01%
500
-700
-58% -$22.4K
AKYA
13118
PUT
DELISTED
Akoya BioSciences
AKYA
$16.4K ﹤0.01%
2,000
+1,800
+900% +$18.8K
ZSL icon
13119
ProShares UltraShort Silver
ZSL
$58M
$16.3K ﹤0.01%
22
-138
-86% -$121K
AEYE icon
13120
PUT
AudioEye
AEYE
$100M
$16.3K ﹤0.01%
2,300
+1,800
+360% +$10.2K
PLYA
13121
PUT
DELISTED
Playa Hotels & Resorts
PLYA
$16.3K ﹤0.01%
1,700
+1,300
+325% +$10.4K
LASR icon
13122
PUT
nLIGHT
LASR
$3.03B
$16.3K ﹤0.01%
+1,600
New +$18.4K
WGS icon
13123
PUT
GeneDx Holdings
WGS
$2.33B
$16.3K ﹤0.01%
1,352
+140
+12% +$1.87K
ALXO icon
13124
CALL
ALX Oncology
ALXO
$271M
$16.3K ﹤0.01%
3,600
-1,600
-31% -$12.1K
WKSP icon
13125
Worksport
WKSP
$10.7M
$16.3K ﹤0.01%
1,113
+1,045
+1,537% +$14.7K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.